294 related articles for article (PubMed ID: 29243775)
1. Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer.
Zhao LP; Li RH; Han DM; Zhang XQ; Nian GX; Wu MX; Feng Y; Zhang L; Sun ZG
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5353-5360. PubMed ID: 29243775
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation.
Li YJ; Yang Z; Wang YY; Wang Y
Mol Oncol; 2019 Nov; 13(11):2375-2392. PubMed ID: 31420931
[TBL] [Abstract][Full Text] [Related]
3. High expression of LncRNA CASC15 is a risk factor for gastric cancer prognosis and promote the proliferation of gastric cancer.
Yao XM; Tang JH; Zhu H; Jing Y
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5661-5667. PubMed ID: 29272000
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.
Guan MM; Rao QX; Huang ML; Wang LJ; Lin SD; Chen Q; Liu CH
Med Sci Monit; 2019 Oct; 25():8131-8141. PubMed ID: 31663517
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Long Noncoding RNA ZNF667-AS1 as a Potential Biomarker for Diagnosis and Prognosis of Glioma Patients.
Yuan Q; Gao C; Lai XD; Chen LY; Lai TB
Dis Markers; 2020; 2020():8895968. PubMed ID: 33282010
[TBL] [Abstract][Full Text] [Related]
6. lncRNA ZNF667-AS1 (NR_036521.1) inhibits the progression of colorectal cancer via regulating ANK2/JAK2 expression.
Zhuang L; Ding W; Ding W; Zhang Q; Xu X; Xi D
J Cell Physiol; 2021 Mar; 236(3):2178-2193. PubMed ID: 32853419
[TBL] [Abstract][Full Text] [Related]
7. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.
Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J
Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975
[TBL] [Abstract][Full Text] [Related]
8. IncRNA ZNF667-AS1 Suppresses Epithelial Mesenchymal Transformation by Targeting TGF-β1 in Oral Squamous Cell Carcinoma.
Zhao J; Cui Z; Dong Z; Niu Y; Yang K; Han H
Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258957
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer.
Huang HW; Xie H; Ma X; Zhao F; Gao Y
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264
[TBL] [Abstract][Full Text] [Related]
10. Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma.
Dong Z; Li S; Wu X; Niu Y; Liang X; Yang L; Guo Y; Shen S; Liang J; Guo W
Cell Death Dis; 2019 Dec; 10(12):930. PubMed ID: 31804468
[TBL] [Abstract][Full Text] [Related]
11. LncRNA ZNF667-AS1 inhibits inflammatory response and promotes recovery of spinal cord injury via suppressing JAK-STAT pathway.
Li JW; Kuang Y; Chen L; Wang JF
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7614-7620. PubMed ID: 30536300
[TBL] [Abstract][Full Text] [Related]
12. lncRNA DLG1-AS1 Promotes Cell Proliferation by Competitively Binding with miR-107 and Up-Regulating ZHX1 Expression in Cervical Cancer.
Rui X; Xu Y; Huang Y; Ji L; Jiang X
Cell Physiol Biochem; 2018; 49(5):1792-1803. PubMed ID: 30231238
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
Zhuang H; Cao G; Kou C; Li D
J BUON; 2019; 24(4):1441-1448. PubMed ID: 31646789
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
Rui X; Xu Y; Jiang X; Ye W; Huang Y; Jiang J
Cell Death Dis; 2018 Dec; 9(12):1175. PubMed ID: 30518760
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
Liu CN; Zhang HY; Liu CL; Wang CC
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
[TBL] [Abstract][Full Text] [Related]
16. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
17. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway.
Li H; Jia Y; Cheng J; Liu G; Song F
Cell Death Dis; 2018 Feb; 9(2):198. PubMed ID: 29416014
[TBL] [Abstract][Full Text] [Related]
19. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
